Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Net Cash Flow (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Net Cash Flow for 8 consecutive years, with -$26.9 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow changed N/A to -$26.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$34.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$24.9 million for FY2025, 561.91% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$26.9 million at Actinium Pharmaceuticals, down from -$7.6 million in the prior quarter.
  • The five-year high for Net Cash Flow was $44.3 million in Q2 2022, with the low at -$26.9 million in Q4 2025.
  • Average Net Cash Flow over 5 years is -$1.1 million, with a median of -$4.2 million recorded in 2022.
  • Peak annual rise in Net Cash Flow hit 358.75% in 2022, while the deepest fall reached 3610.83% in 2022.
  • Over 5 years, Net Cash Flow stood at -$4.3 million in 2021, then skyrocketed by 31.76% to -$2.9 million in 2022, then plummeted by 117.1% to -$6.3 million in 2023, then decreased by 17.07% to -$7.4 million in 2024, then tumbled by 264.75% to -$26.9 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$26.9 million, -$7.6 million, and -$7.4 million for Q4 2025, Q1 2025, and Q3 2024 respectively.